Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients

This study has been completed.
Sponsor:
Collaborators:
Heidelberg University
Astellas Pharma Inc
Hoffmann-La Roche
Aventis Pharmaceuticals
Information provided by:
University of Giessen
ClinicalTrials.gov Identifier:
NCT00176059
First received: September 9, 2005
Last updated: May 8, 2007
Last verified: May 2007